These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7164279)

  • 1. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

  • 2. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA; Sefton MV
    J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
    Hatton MW; Rollason G; Sefton MV
    Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditions for radioiodination of antithrombin III retaining its biological properties.
    Caix J; Perrot Minnot A; Beziade A; Vuillemin L; Belloc F; Baquey C; Ducassou D
    Int J Rad Appl Instrum A; 1987; 38(12):1003-6. PubMed ID: 2828272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G; Nagasawa K
    Thromb Res; 1986 May; 42(3):375-82. PubMed ID: 3715809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of thrombin by antithrombin III on a heparinized biomaterial.
    Goosen MF; Sefton MV; Hatton MW
    Thromb Res; 1980 Dec 1-15; 20(5-6):543-54. PubMed ID: 7233384
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular weight analysis of antithrombin III-heparin and antithrombin III-thrombin-heparin complexes.
    Pletcher CH; Cunningham MT; Nelsestuen GL
    J Biol Chem; 1986 Mar; 261(9):4143-7. PubMed ID: 3949807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of antithrombin III and thrombin to immobilized heparin under flow conditions.
    Byun Y; Jacobs HA; Kim SW
    Biotechnol Prog; 1996; 12(2):217-25. PubMed ID: 8857192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW; Berry LR; Kaur H; Koj A; Regoeczi E
    Can J Biochem; 1979 Oct; 57(10):1183-90. PubMed ID: 120212
    [No Abstract]   [Full Text] [Related]  

  • 13. Dependence of antithrombin III and thrombin binding stoichiometries and catalytic activity on the molecular weight of affinity-purified heparin.
    Nesheim M; Blackburn MN; Lawler CM; Mann KG
    J Biol Chem; 1986 Mar; 261(7):3214-21. PubMed ID: 3949769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of proteases, antithrombin III, and heparin.
    Downing MR
    J Lab Clin Med; 1980 Jun; 95(6):777-82. PubMed ID: 6991619
    [No Abstract]   [Full Text] [Related]  

  • 15. On the reliability of the use of heparin immobilized on agarose for the study of the interactions among heparin, thrombin and antithrombin.
    Fish WW; Björk I
    Thromb Haemost; 1982 Aug; 48(1):84-6. PubMed ID: 7135347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of heparin binding to antithrombin III by crossed immunoelectrophoresis.
    Barrowcliffe TW
    Thromb Haemost; 1980 Feb; 42(5):1434-45. PubMed ID: 7368150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitors of human plasma. Antithrombin-III. "The heparin-antithrombin system".
    Rosenberg RD; Bauer KA; Marcum JA
    J Med; 1985; 16(1-3):351-416. PubMed ID: 3915998
    [No Abstract]   [Full Text] [Related]  

  • 20. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.